Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<sec> <title>BACKGROUND</title> <p>COVID-19 presents unique challenges in healthcare, including mental health care provision. Telepsychiatry can provide an alternative to face to face assessment and also be used creatively with other technologies to enhance care, but clinicians and patients may feel underconfident about embracing this new way of working.</p> </sec> <sec> <title>OBJECTIVE</title> <p>Using an evidence-based approach we provide an open access, easy-to-consult and reliable source of information and guidance on all topics related to COVID-19 and digital mental health.</p> </sec> <sec> <title>METHODS</title> <p>We systematically searched guidance related to COVID-19 and digital mental health and summarised the data as answers to specific clinical questions.</p> </sec> <sec> <title>RESULTS</title> <p>Findings from this study reflected the strong evidence base for the use of telepsychiatry and covered guidance for many of the common concerns expressed by clinicians about practical implementation, technology, information governance and safety. Guidance across countries differs significantly, with UK guidance more conservative and focussed on practical implementation, and US guidance more expansive and detailed. Guidance on possible combination with other digital technologies such as apps, for example from the FDA, NHS Apps Library and NICE is less detailed. Several key areas were not represented. Whilst some special populations such as child and adolescent, older adult and cultural issues are specifically included, important populations such as learning disabilities, psychosis, personality disorder and eating disorders, which may present particular challenges for telepsychiatry, are not. In addition, initial consultation and follow-up sessions are not clearly distinguished in the guidance. Finally, a hybrid model of care (combining telepsychiatry with other technologies and in-person care) is not explicitly covered by the existing guidelines.</p> </sec> <sec> <title>CONCLUSIONS</title> <p>We produced a comprehensive synthesis of guidance answering a wide range of clinical questions in telepsychiatry. This meets the urgent need for practical information for both clinicians and health care organisations who are rapidly adapting to the pandemic and implementing remote consultation. It reflects variations across countries and can be used as basis for organisational change in the short and longer term. Providing easily accessible guidance is a first step, but will need cultural change to implement, as clinicians start to view telepsychiatry not just as a replacement, but as a parallel and complimentary form of delivering therapy, with its own advantages and benefits as well as restrictions. A combination or hybrid approach can be the most successful approach in the new world of mental health post-COVID-19 and guidance will need to expand to encompass the use of telepsychiatry in conjunction with other in-person and digital technologies, and also its use across all psychiatric disorders, not just those who are the first to access and engage with remote treatment.</p> </sec>

Original publication

DOI

10.2196/preprints.21108

Type

Journal article

Publisher

JMIR Publications Inc.

Publication Date

05/06/2020